TegoScience Inc. (KOSDAQ:191420)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,030
+70 (0.59%)
At close: Mar 12, 2026
Market Cap96.32B -40.1%
Revenue (ttm)6.15B -11.2%
Net Income-3.25B
EPS-406.28
Shares Out8.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,353
Average Volume16,833
Open11,970
Previous Close11,960
Day's Range11,960 - 12,300
52-Week Range11,090 - 20,250
Beta0.87
RSI34.16
Earnings DateNov 14, 2025

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 191420
Full Company Profile

Financial Performance

Financial Statements